What triggered Morpho's latest price pullback

Traders Union
All News
Crypto
Morpho slides 10.3% today to $1.681

Highlights

Morpho secured $175 million in funding co-led by Paradigm and a16z Crypto, reaching a near $2 billion valuation.
The protocol expanded through BitGo partnership for regulated DeFi vaults and continues to see high on-chain activity despite weak price action.
Technicals show persistent bearish momentum, with MORPHO/USD likely to consolidate below $1.779 and a downside target near $1.5485.

Investor flows steady as protocol expands amid price pressure

Morpho completed a $175 million funding round co-led by Paradigm and a16z Crypto, establishing a valuation near $2 billion. The raise featured a monthly average token purchase structure for gradual price discovery. Morpho also recorded billions in deposits and loans on its protocol and announced a partnership with BitGo to offer regulated DeFi vaults. Reports highlighted Morpho’s continued activity and protocol expansion, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees Morpho’s sharp price drop as a signal of persistent structural weakness. He notes that funding news and partnerships have failed to mitigate heavy selling pressure. Technicals reinforce the negative sentiment, with price below both the 20-day and 50-day averages, and key oscillators flashing oversold yet still bearish signals. He highlights that high volatility and weak momentum indicators warn of further downside, especially if $1.678 fails to hold. "Despite positive headlines, I see significant risk of another leg lower toward $1.5485 unless buyers step in at crucial support levels."

Viktoras Karapetjanc, expert at Traders Union, points to Morpho’s successful $175 million funding and major institutional partnerships as foundational positives. He believes the protocol’s billions in deposits and expansion into regulated DeFi with BitGo indicate real adoption momentum. Karapetjanc sees short-term price weakness as an opportunity, since the long-term bullish structure remains intact above the 200-day average. "With such strong backers and sustained protocol growth, I expect Morpho to recover and offer forward-looking upside potential for investors."

Parshwa Turakhiya, analyst, observes Morpho’s market mood shifting rapidly after the steep selloff. He highlights that negative momentum dominates, but the RSI and Stochastic RSI suggest possible short-term oversold bounce scenarios for nimble traders. Turakhiya notes that volatility at 7.03% can create quick, sentiment-driven setups near support and resistance levels. "Opportunity arises if $1.678 holds as a launchpad for a technical rebound, but tight risk management is key in such a choppy environment."

Bearish momentum outweighs support levels amid oversold signals

MORPHO/USD is trading below its 20-day and 50-day moving averages at $1.8708 and $1.9704, but remains just above the 200-day average at $1.6118. This setup points to prevailing short- and medium-term selling pressure, while keeping a longer-term bullish structure intact. The near-term ceiling stands at $1.779, with immediate support at $1.678. Bearish momentum continues, as the MACD signals selling and the ADX remains weak. The RSI at 39.27 suggests additional downside risk, while the Stochastic RSI at 0 and CCI at -50.82 both indicate oversold conditions. Bull/Bear Power (BBP) at -0.0115 and the Awesome Oscillator further support a bearish tone. The pair is currently trading near its intraday low with heightened volatility at 7.03%.

Earlier, analysts noted that Morpho was experiencing persistent downside momentum despite institutional expansion and new capital inflows. The latest price action confirms continued bearish pressure, making sustained support above $1.678 critical for short-term stability as volatility remains elevated.

Source of Data: MORPHO Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.